Institution
University of Houston
Education•Houston, Texas, United States•
About: University of Houston is a education organization based out in Houston, Texas, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 23074 authors who have published 53903 publications receiving 1641968 citations.
Topics: Population, Poison control, Anxiety, Context (language use), Catalysis
Papers published on a yearly basis
Papers
More filters
••
University of Washington1, University of North Carolina at Chapel Hill2, Veterans Health Administration3, Columbia University4, University of Houston5, Harvard University6, Mayo Clinic7, Cincinnati Children's Hospital Medical Center8, Icahn School of Medicine at Mount Sinai9, Geisinger Medical Center10, University of Minnesota11
TL;DR: Research investigators should be prepared to return research results and incidental findings discovered in the course of their research and meeting an actionability threshold, but they have no ethical obligation to actively search for such results.
Abstract: As more research studies incorporate next-generation sequencing (including whole-genome or whole-exome sequencing), investigators and institutional review boards face difficult questions regarding which genomic results to return to research participants and how. An American College of Medical Genetics and Genomics 2013 policy paper suggesting that pathogenic mutations in 56 specified genes should be returned in the clinical setting has raised the question of whether comparable recommendations should be considered in research settings. The Clinical Sequencing Exploratory Research (CSER) Consortium and the Electronic Medical Records and Genomics (eMERGE) Network are multisite research programs that aim to develop practical strategies for addressing questions concerning the return of results in genomic research. CSER and eMERGE committees have identified areas of consensus regarding the return of genomic results to research participants. In most circumstances, if results meet an actionability threshold for return and the research participant has consented to return, genomic results, along with referral for appropriate clinical follow-up, should be offered to participants. However, participants have a right to decline the receipt of genomic results, even when doing so might be viewed as a threat to the participants' health. Research investigators should be prepared to return research results and incidental findings discovered in the course of their research and meeting an actionability threshold, but they have no ethical obligation to actively search for such results. These positions are consistent with the recognition that clinical research is distinct from medical care in both its aims and its guiding moral principles.
339 citations
••
TL;DR: A measurement of the energy dependence of antineutrino disappearance at the Daya Bay reactor neutrino experiment is reported, supporting the three-flavor oscillation model.
Abstract: A measurement of the energy dependence of antineutrino disappearance at the Daya Bay reactor neutrino experiment is reported. Electron antineutrinos (ν¯_e) from six 2.9 GW_(th) reactors were detected with six detectors deployed in two near (effective baselines 512 and 561 m) and one far (1579 m) underground experimental halls. Using 217 days of data, 41 589 (203 809 and 92 912) antineutrino candidates were detected in the far hall (near halls). An improved measurement of the oscillation amplitude sin^2 2θ_(13) = 0.090^(+0.008)_(−0.009) and the first direct measurement of the ν¯e mass-squared difference |Δm2ee|=(2.59^(+0.19)_(−0.20))×10^−3 eV^2 is obtained using the observed ν¯_e rates and energy spectra in a three-neutrino framework. This value of |Δm^(2)_(ee)| is consistent with |Δm^(2)_(μμ)| measured by muon neutrino disappearance, supporting the three-flavor oscillation model.
339 citations
••
TL;DR: It is demonstrated that beta ARK1 appears to be the predominant GRK in early embryogenesis and that it plays a fundamental role in cardiac development.
Abstract: The beta-adrenergic receptor kinase 1 (beta ARK1) is a member of the G protein-coupled receptor kinase (GRK) family that mediates the agonist-dependent phosphorylation and desensitization of G protein-coupled receptors. We have cloned and disrupted the beta ARK1 gene in mice by homologous recombination. No homozygote beta ARK1-/- embryos survive beyond gestational day 15.5. Prior to gestational day 15.5, beta ARK1-/- embryos display pronounced hypoplasia of the ventricular myocardium essentially identical to the "thin myocardium syndrome" observed upon gene inactivation of several transcription factors (RXR alpha, N-myc, TEF-1, WT-1). Lethality in beta ARK1-/- embryos is likely due to heart failure as they exhibit a > 70% decrease in cardiac ejection fraction determined by direct in utero intravital microscopy. These results along with the virtual absence of endogenous GRK activity in beta ARK1-/- embryos demonstrate that beta ARK1 appears to be the predominant GRK in early embryogenesis and that it plays a fundamental role in cardiac development.
339 citations
••
TL;DR: Palladium-catalyzed C-H activation: cheap aryl chlorides can now be used for the arylation of a wide variety of electron-rich heterocycles, and the key to the success is the use of a bulky, electron- rich phosphine ligand.
339 citations
••
TL;DR: It is suggested that CRF may be accurately estimated in adults from a non-exercise test model including gender, age, body mass index, resting heart rate, and self-reported physical activity.
339 citations
Authors
Showing all 23345 results
Name | H-index | Papers | Citations |
---|---|---|---|
Matthew Meyerson | 194 | 553 | 243726 |
Gad Getz | 189 | 520 | 247560 |
Eric Boerwinkle | 183 | 1321 | 170971 |
Pulickel M. Ajayan | 176 | 1223 | 136241 |
Zhenan Bao | 169 | 865 | 106571 |
Marc Weber | 167 | 2716 | 153502 |
Steven N. Blair | 165 | 879 | 132929 |
Martin Karplus | 163 | 831 | 138492 |
Dongyuan Zhao | 160 | 872 | 106451 |
Xiang Zhang | 154 | 1733 | 117576 |
Jan-Åke Gustafsson | 147 | 1058 | 98804 |
James M. Tour | 143 | 859 | 91364 |
Guanrong Chen | 141 | 1652 | 92218 |
Naomi J. Halas | 140 | 435 | 82040 |
Antonios G. Mikos | 138 | 694 | 70204 |